Please complete the CAPTCHA to continue
@flavinventures.com
✓
5 phones found area 574 and 630
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael Flavin is listed as Managing Director at Flavin Ventures at Flavin Ventures, LLC, a company with 4 employees, based in Greater Chicago Area, United States, United States. AeroLeads shows a work email signal at flavinventures.com, phone signal with area code 574, 630, and a matched LinkedIn profile for Michael Flavin.
Michael Flavin previously worked as Managing Director at Flavin Ventures, Llc and Chief Executive Officer at Shamrock Structures, Llc. Michael Flavin holds Postdoctoral Fellowship, Synthetic Organic Chemistry from Harvard University.
This section adds company-level context without repeating Michael Flavin's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael Flavin. Compare company email patterns before reaching out.
Michael T. Flavin is CEO of Shamrock Structures, a drug discovery services company founded in 2003 to provide pharmaceutical researchers with access to technologies and expertise to accelerate their lead compound discovery programs. Shamrock’s combination of protein target structure determination using x-ray crystallography, medicinal chemistry to synthesize new compounds that bind to the protein target and biological screening to determine the resulting biological effect of the new compounds is a powerful approach to creating more potent and selective new drugs. He is also Chairman & CEO of Advanced Life Sciences (ADLS.OB), a biopharmaceutical company focused on the development of new drugs to fight infection, inflammation and cancer. Founded in 1999, Advanced Life Sciences completed a $35M IPO in 2005 and several follow-on financings to advance drugs through clinical trials. including RestanzaTM (cethromycin), a novel once-a-day oral antibiotic in NDA-stage development for thetreatment of respiratory tract infections including pneumonia. In 1987, Dr. Flavin founded MediChem Life Sciences (NASDAQ: MCLS).He established MediChem as a premier drug discovery and development company for the pharmaceutical industry. In 2000, MediChem completed a $54M IPO. Dr. Flavin has 45 publications in scientific journals and 20 U.S. patents in the fields of organic chemistry, medicinal chemistry and biochemistry. He has been awarded several grants from the National Institutes of Health to further his research in anti-infective and anticancer drug discovery. Dr. Flavin is a frequent lecturer on topics related to scientific entrepreneurship at universities such as Notre Dame and the University of Chicago. Dr. Flavin received his B.S. degree in chemistry from Notre Dame and his Ph.D. degree in medicinal chemistry from University of Illinois at Chicago. After completing his postdoctoral fellowship at Harvard, he was a Senior Research Scientist at Baxter prior to founding MediChem.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Woodridge, IL
Established in 2002, Flavin Ventures is a business advisory firm that provides strategic management to life science companies with high growth opportunity. The Company’s services allow clients to fill project specific and interim management requirements utilizing the professional services of commercially experienced senior executives with capabilities that.
Woodridge, IL
Shamrock Structures is a drug discovery services company founded in 2003 to provide pharmaceutical researchers with access to technologies and expertise to accelerate their lead compound discovery programs. Shamrock’s combination of protein target structure determination using x-ray crystallography, medicinal chemistry to synthesize new compounds that bind.
Woodridge, IL
Advanced Life Sciences (ADLS.OB) is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection and oncology. The Company’s lead candidate, RestanzaTM, is a novel once-a-day oral antibiotic in NDA-stage development for the treatment of infections.
Woodridge, IL
MediChem (NASDAQ: MCLS) was a drug discovery technology and services company that specialized in structural proteomics, medicinal chemistry, process research, biocatalysis and cGMP scale-up in accelerating drug discovery and development. In March, 2002, MediChem merged with deCODE genetics (NASDAQ: DCGN) to convert information about genes involved with.
Instructor in “Scientific Entrepreneurship” course in the College of Science.
Occasional lecturer in Professor Scott Meadow’s “Commercializing Innovation” MBA course in scientific and technical entrepreneurship.
Taught course in heterocyclic chemistry to graduate students in the Department of Medicinal Chemistry and Pharmacognosy.
Designed and synthesized a variety of organic compounds as potential new drugs or products for the health care industry. Developed expertise in anti-inflammatory drug discovery and development.
Investigated synthetic approaches to the total synthesis of the antitumor antibiotic nogalamycin in the laboratory of Professor Yoshito.
Studied the molecular and conformational requirements of the cholinergic muscarinic receptor in the laboratory of Professor Matthias Lu..
Carried out enzyme purification using chromatography techniques in the laboratory of Professor Roger Bretthauer.
Quick answers generated from the profile data available on this page.
Michael Flavin works for Flavin Ventures, LLC.
Michael Flavin is listed as Managing Director at Flavin Ventures at Flavin Ventures, LLC.
AeroLeads has found 1 work email signal at @flavinventures.com for Michael Flavin at Flavin Ventures, LLC.
AeroLeads has found 5 phone signal(s) with area code 574, 630 for Michael Flavin at Flavin Ventures, LLC.
Michael Flavin is based in Greater Chicago Area, United States, United States while working with Flavin Ventures, LLC.
Michael Flavin has worked for Flavin Ventures, Llc, Shamrock Structures, Llc, Advanced Life Sciences, Inc., Medichem Life Sciences, Inc., and University Of Notre Dame.
You can use AeroLeads to view verified contact signals for Michael Flavin at Flavin Ventures, LLC, including work email, phone, and LinkedIn data when available.
Michael Flavin holds Postdoctoral Fellowship, Synthetic Organic Chemistry from Harvard University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Michael Flavin you were looking for.
